Xinyin Han
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Xinyin Han has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
- Beifang Niu
Computer Network Information Center, Chinese Academy of Sciences, Beijing, China
5 shared publications - Ruilin Li
Computer Network Information Center, Chinese Academy of Sciences, Beijing 100190, China; University of Chinese Academy of Sciences, Beijing 100190, China
3 shared publications - Xiaoyu He
Computer Network Information Center, Chinese Academy of Sciences, Beijing 100190, China; University of Chinese Academy of Sciences, Beijing 100190, China
3 shared publications - Xuebin Chi
Computer Network Information Center, Chinese Academy of Sciences, Beijing, China
3 shared publications - Zhonghua Lu
Computer Network Information Center, Chinese Academy of Sciences, Beijing, China
3 shared publications - Chuangchuang Dai
Computer Network Information Center, Chinese Academy of Sciences, Beijing 100190, China; University of Chinese Academy of Sciences, Beijing 100190, China
2 shared publications
Latest Publications
- 27 March 2025
- Published by World Scientific Pub Co Pte Ltd in International Journal of Biomathematics
Integrative subtyping of nonsmall cell lung cancer using histopathology and multi-omics data
Nonsmall cell lung cancer (NSCLC), encompassing lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC), is a major global health challenge due to its high mortality rate. Current molecular classifications of NSCLC fail to adequately integrate subtype-specific molecular and phenotypic differences, and many are not directly applicable to clinical diagnosis, treatment, or prognosis guidance. To address this, we develop a machine learning-based tumor subtyping framework, Morphgene, that integrates morphological analysis from Hematoxylin and Eosin (H&E) stained slides with multiomics data, successfully delineating four distinct survival-related subtypes for both LUAD and LUSC. Our analysis identifies unique molecular profiles and treatment responses for these subtypes: LUAD’s Cluster C is characterized by low mutation rates and EGFR mutations, showing resistance to immunotherapy but sensitivity to targeted therapies. In contrast, LUAD’s Cluster B and LUSC’s Cluster D are likely to benefit from immunotherapy. LUSC’s Cluster A also shows enhanced survival with chemoradiotherapy. This integrated subtyping approach provides clearer insights for personalized treatment strategies in NSCLC.
- 27 March 2025
- Published by World Scientific Pub Co Pte Ltd in International Journal of Biomathematics
Integrative subtyping of nonsmall cell lung cancer using histopathology and multi-omics data
Nonsmall cell lung cancer (NSCLC), encompassing lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC), is a major global health challenge due to its high mortality rate. Current molecular classifications of NSCLC fail to adequately integrate subtype-specific molecular and phenotypic differences, and many are not directly applicable to clinical diagnosis, treatment, or prognosis guidance. To address this, we develop a machine learning-based tumor subtyping framework, Morphgene, that integrates morphological analysis from Hematoxylin and Eosin (H&E) stained slides with multiomics data, successfully delineating four distinct survival-related subtypes for both LUAD and LUSC. Our analysis identifies unique molecular profiles and treatment responses for these subtypes: LUAD’s Cluster C is characterized by low mutation rates and EGFR mutations, showing resistance to immunotherapy but sensitivity to targeted therapies. In contrast, LUAD’s Cluster B and LUSC’s Cluster D are likely to benefit from immunotherapy. LUSC’s Cluster A also shows enhanced survival with chemoradiotherapy. This integrated subtyping approach provides clearer insights for personalized treatment strategies in NSCLC.
- Open Access
- 18 January 2021
- Published by Oxford University Press (OUP) in Briefings in Bioinformatics
- Vol. 22 (5)
MSIsensor-ct: microsatellite instability detection using cfDNA sequencing data
Motivation: Microsatellite instability (MSI) is a promising biomarker for cancer prognosis and chemosensitivity. Techniques are rapidly evolving for the detection of MSI from tumor-normal paired or tumor-only sequencing data. However, tumor tissues are often insufficient, unavailable, or otherwise difficult to procure. Increasing clinical evidence indicates the enormous potential of plasma circulating cell-free DNA (cfNDA) technology as a noninvasive MSI detection approach. Results: We developed MSIsensor-ct, a bioinformatics tool based on a machine learning protocol, dedicated to detecting MSI status using cfDNA sequencing data with a potential stable MSIscore threshold of 20%. Evaluation of MSIsensor-ct on independent testing datasets with various levels of circulating tumor DNA (ctDNA) and sequencing depth showed 100% accuracy within the limit of detection (LOD) of 0.05% ctDNA content. MSIsensor-ct requires only BAM files as input, rendering it user-friendly and readily integrated into next generation sequencing (NGS) analysis pipelines. Availability: MSIsensor-ct is freely available at https://github.com/niu-lab/MSIsensor-ct. Supplementary information: Supplementary data are available at Briefings in Bioinformatics online.
- 18 January 2021
- Published by Oxford University Press (OUP) in Briefings in Bioinformatics
- Vol. 22 (5)
Open AccessMSIsensor-ct: microsatellite instability detection using cfDNA sequencing data
Motivation: Microsatellite instability (MSI) is a promising biomarker for cancer prognosis and chemosensitivity. Techniques are rapidly evolving for the detection of MSI from tumor-normal paired or tumor-only sequencing data. However, tumor tissues are often insufficient, unavailable, or otherwise difficult to procure. Increasing clinical evidence indicates the enormous potential of plasma circulating cell-free DNA (cfNDA) technology as a noninvasive MSI detection approach. Results: We developed MSIsensor-ct, a bioinformatics tool based on a machine learning protocol, dedicated to detecting MSI status using cfDNA sequencing data with a potential stable MSIscore threshold of 20%. Evaluation of MSIsensor-ct on independent testing datasets with various levels of circulating tumor DNA (ctDNA) and sequencing depth showed 100% accuracy within the limit of detection (LOD) of 0.05% ctDNA content. MSIsensor-ct requires only BAM files as input, rendering it user-friendly and readily integrated into next generation sequencing (NGS) analysis pipelines. Availability: MSIsensor-ct is freely available at https://github.com/niu-lab/MSIsensor-ct. Supplementary information: Supplementary data are available at Briefings in Bioinformatics online.
- Open Access
Predicting the required pre-surgery blood volume in surgical patients based on machine learning
Precisely predicting the required pre-surgery blood volume (PBV) in surgical patients is a formidable challenge in China. Inaccurate estimation is associate with excessive costs, postponed surgeries and adverse outcome after surgery due to in sufficient supply or inventory. This study aimed to predict required PBV based on machine learning techniques. 181,027 medical documents over 6 years were cleaned and finally obtained 92,057 blood transfusion records. The blood transfusion and surgery related factors of perioperative patients, surgeons experience volumes and the actual volumes of transfused RBCs were extracted. 6 machine learning algorithms were used to build prediction models. The surgery patients received allogenic RBCs or without transfusion, had total volume less than 10 units, or had the latest laboratory examinations of pre-surgery within 7 days were included, providing 118,823 data points. 39 predictive factors related to the RBCs transfusion were identified. Random forest model was selected to predict the required PBV of RBCs with 72.9% accuracy and strikingly improved the accuracy by 30.4% compared with surgeons experience, where 90% of data was used for training. We tested and demonstrated that both the data-driven models and the random forest model achieved higher accuracy than surgeons experience. Furthermore, we developed a computational tool, PTRBC, to precisely estimate the required PBV in surgical patients and we believe this tool will find more applications in assisting clinician decisions, not only confined to making accurate pre-surgery blood requirement predicting.
Open AccessPredicting the required pre-surgery blood volume in surgical patients based on machine learning
Precisely predicting the required pre-surgery blood volume (PBV) in surgical patients is a formidable challenge in China. Inaccurate estimation is associate with excessive costs, postponed surgeries and adverse outcome after surgery due to in sufficient supply or inventory. This study aimed to predict required PBV based on machine learning techniques. 181,027 medical documents over 6 years were cleaned and finally obtained 92,057 blood transfusion records. The blood transfusion and surgery related factors of perioperative patients, surgeons experience volumes and the actual volumes of transfused RBCs were extracted. 6 machine learning algorithms were used to build prediction models. The surgery patients received allogenic RBCs or without transfusion, had total volume less than 10 units, or had the latest laboratory examinations of pre-surgery within 7 days were included, providing 118,823 data points. 39 predictive factors related to the RBCs transfusion were identified. Random forest model was selected to predict the required PBV of RBCs with 72.9% accuracy and strikingly improved the accuracy by 30.4% compared with surgeons experience, where 90% of data was used for training. We tested and demonstrated that both the data-driven models and the random forest model achieved higher accuracy than surgeons experience. Furthermore, we developed a computational tool, PTRBC, to precisely estimate the required PBV in surgical patients and we believe this tool will find more applications in assisting clinician decisions, not only confined to making accurate pre-surgery blood requirement predicting.
- Open Access
- 1 October 2019
- Published by Oxford University Press (OUP) in Genomics, Proteomics & Bioinformatics
- Vol. 17 (5) , 496-502
Gclust: A Parallel Clustering Tool for Microbial Genomic Data
The accelerating growth of the public microbial genomic data imposes substantial burden on the research community that uses such resources. Building databases for non-redundant reference sequences from massive microbial genomic data based on clustering analysis is essential. However, existing clustering algorithms perform poorly on long genomic sequences. In this article, we present Gclust, a parallel program for clustering complete or draft genomic sequences, where clustering is accelerated with a novel parallelization strategy and a fast sequence comparison algorithm using sparse suffix arrays (SSAs). Moreover, genome identity measures between two sequences are calculated based on their maximal exact matches (MEMs). In this paper, we demonstrate the high speed and clustering quality of Gclust by examining four genome sequence datasets. Gclust is freely available for non-commercial use at https://github.com/niu-lab/gclust. We also introduce a web server for clustering user-uploaded genomes at http://niulab.scgrid.cn/gclust.
- 1 October 2019
- Published by Oxford University Press (OUP) in Genomics, Proteomics & Bioinformatics
- Vol. 17 (5) , 496-502
Open AccessGclust: A Parallel Clustering Tool for Microbial Genomic Data
The accelerating growth of the public microbial genomic data imposes substantial burden on the research community that uses such resources. Building databases for non-redundant reference sequences from massive microbial genomic data based on clustering analysis is essential. However, existing clustering algorithms perform poorly on long genomic sequences. In this article, we present Gclust, a parallel program for clustering complete or draft genomic sequences, where clustering is accelerated with a novel parallelization strategy and a fast sequence comparison algorithm using sparse suffix arrays (SSAs). Moreover, genome identity measures between two sequences are calculated based on their maximal exact matches (MEMs). In this paper, we demonstrate the high speed and clustering quality of Gclust by examining four genome sequence datasets. Gclust is freely available for non-commercial use at https://github.com/niu-lab/gclust. We also introduce a web server for clustering user-uploaded genomes at http://niulab.scgrid.cn/gclust.
- Open Access
- 1 August 2019
- Published by Oxford University Press (OUP) in Genomics, Proteomics & Bioinformatics
- Vol. 17 (4) , 381-392
How Big Data and High-Performance Computing Drive Brain Science
Brain science accelerates the study of intelligence and behavior, contributes fundamental insights into human cognition, and offers prospective treatments for brain disease. Faced with the challenges posed by imaging technologies and deep learning computational models, big data and high-performance computing (HPC) play essential roles in studying brain function, brain diseases, and large-scale brain models or connectomes. We review the driving forces behind big data and HPC methods applied to brain science, including deep learning, powerful data analysis capabilities, and computational performance solutions, each of which can be used to improve diagnostic accuracy and research output. This work reinforces predictions that big data and HPC will continue to improve brain science by making ultrahigh-performance analysis possible, by improving data standardization and sharing, and by providing new neuromorphic insights.
- 1 August 2019
- Published by Oxford University Press (OUP) in Genomics, Proteomics & Bioinformatics
- Vol. 17 (4) , 381-392
Open AccessHow Big Data and High-Performance Computing Drive Brain Science
Brain science accelerates the study of intelligence and behavior, contributes fundamental insights into human cognition, and offers prospective treatments for brain disease. Faced with the challenges posed by imaging technologies and deep learning computational models, big data and high-performance computing (HPC) play essential roles in studying brain function, brain diseases, and large-scale brain models or connectomes. We review the driving forces behind big data and HPC methods applied to brain science, including deep learning, powerful data analysis capabilities, and computational performance solutions, each of which can be used to improve diagnostic accuracy and research output. This work reinforces predictions that big data and HPC will continue to improve brain science by making ultrahigh-performance analysis possible, by improving data standardization and sharing, and by providing new neuromorphic insights.